A Phase II Head-to-Head Comparison of Fertility-Sparing Approaches to Treat Complex Atypical Hyperplasia of the Endometrium: Megestrol Versus Levonorgestrel-Releasing Intrauterine System (LNG-IUS)

Trial Profile

A Phase II Head-to-Head Comparison of Fertility-Sparing Approaches to Treat Complex Atypical Hyperplasia of the Endometrium: Megestrol Versus Levonorgestrel-Releasing Intrauterine System (LNG-IUS)

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 09 Sep 2014

At a glance

  • Drugs Levonorgestrel (Primary) ; Megestrol (Primary)
  • Indications Atypical endometrial hyperplasia; Endometrial cancer
  • Focus Biomarker; Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 09 Sep 2014 Status changed from not yet recruiting to withdrawn prior to enrolment as per ClinicalTrials.gov record.
    • 27 Jan 2014 Planned End Date changed from 1 Oct 2016 to 1 Oct 2017 as per ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top